Effect of fusion protein cleavage site sequence on generation of a genotype VII Newcastle disease virus vaccine.

Effect of fusion protein cleavage site sequence on generation of a genotype VII Newcastle disease virus vaccine.

Newcastle disease (ND) causes severe economic loss to poultry industry worldwide. Frequent outbreaks of ND in commercial chickens vaccinated with live vaccines suggest a need to develop improved vaccines that are genetically matched against circulating Newcastle disease virus (NDV) strains. In this...

Full description

Bibliographic Details
Main Authors:	Vinoth K Manoharan, Berin P Varghese, Anandan Paldurai, Siba K Samal
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2018-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5951571?pdf=render

Similar Items

Evaluation of fusion protein cleavage site sequences of Newcastle disease virus in genotype matched vaccines.
by: Shin-Hee Kim, et al.
Published: (2017-01-01)

Newcastle disease virus fusion protein is the major contributor to protective immunity of genotype-matched vaccine.
by: Shin-Hee Kim, et al.
Published: (2013-01-01)

Sequence analysis of fusion protein gene of Newcastle disease virus isolated from outbreaks in Egypt during 2006
by: Paldurai Anandan, et al.
Published: (2011-05-01)

Expression of Concern: Evaluation of fusion protein cleavage site sequences of Newcastle disease virus in genotype matched vaccines.
by: PLOS ONE Editors
Published: (2020-01-01)

Contributions of HA1 and HA2 Subunits of Highly Pathogenic Avian Influenza Virus in Induction of Neutralizing Antibodies and Protection in Chickens
by: Edris Shirvani, et al.
Published: (2020-06-01)

Development of a recombinant Newcastle disease virus-vectored vaccine for infectious bronchitis virus variant strains circulating in Egypt
by: Hassanein H. Abozeid, et al.
Published: (2019-02-01)

Newcastle Disease Virus as a Vaccine Vector for Development of Human and Veterinary Vaccines
by: Shin-Hee Kim, et al.
Published: (2016-07-01)

Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines
by: Shin-Hee Kim, et al.
Published: (2019-03-01)

Newcastle Disease Virus as a Vaccine Vector for SARS-CoV-2
by: Edris Shirvani, et al.
Published: (2020-07-01)

Effects of naturally occurring six- and twelve-nucleotide inserts on Newcastle disease virus replication and pathogenesis.
by: Anandan Paldurai, et al.
Published: (2014-01-01)

Protective efficacy of the Newcastle disease virus genotype VII–matched vaccine in commercial layers
by: Hesham A. Sultan, et al.
Published: (2020-03-01)

Generation by reverse genetics of an effective, stable, live-attenuated newcastle disease virus vaccine based on a currently circulating, highly virulent Indonesian strain.
by: Sa Xiao, et al.
Published: (2012-01-01)

Complete genome sequence of avian paramyxovirus (APMV) serotype 5 completes the analysis of nine APMV serotypes and reveals the longest APMV genome.
by: Arthur S Samuel, et al.
Published: (2010-02-01)

Effectiveness of vaccines produced by the Federal State-Financed Institution “ARRIAH” against topical genotype VII Newcastle disease viruses
by: S. V. Frolov, et al.
Published: (2021-03-01)

Mutations in the fusion protein cleavage site of avian paramyxovirus serotype 4 confer increased replication and syncytium formation in vitro but not increased replication and pathogenicity in chickens and ducks.
by: Shin-Hee Kim, et al.
Published: (2013-01-01)

Molecular characterization of Newcastle disease virus (genotype VII) from broiler chickens in Egypt
by: Samar S. Ewies, et al.
Published: (2017-09-01)

Comprehensive analysis of amino acid sequence diversity at the F protein cleavage site of Newcastle disease virus in fusogenic activity.
by: Yanhong Wang, et al.
Published: (2017-01-01)

Retraction: Newcastle disease virus fusion protein is the major contributor to protective immunity of genotype-matched vaccine.
by: PLOS ONE Editors
Published: (2020-01-01)

In Vivo Production of HN Protein Increases the Protection Rates of a Minicircle DNA Vaccine against Genotype VII Newcastle Disease Virus
by: Zhannan Wang, et al.
Published: (2021-07-01)

Development of genotype VII NDV inactivated vaccine
by: Lin, Wen-Hsiu, et al.
Published: (2015)

Efficacy of a Turkey Herpesvirus Vectored Newcastle Disease Vaccine against Genotype VII.1.1 Virus: Challenge Route Affects Shedding Pattern
by: Vilmos Palya, et al.
Published: (2021-01-01)

The positive expression of genotype VII Newcastle disease virus (Malaysian isolate) in Japanese quails (Coturnix coturnix japonica)
by: Lizma Felisha Mazlan, et al.
Published: (2017-05-01)

Insights into Genomic Epidemiology, Evolution, and Transmission Dynamics of Genotype VII of Class II Newcastle Disease Virus in China
by: Bin Xiang, et al.
Published: (2020-10-01)

Rapid Development of an Effective Newcastle Disease Virus Vaccine Candidate by Attenuation of a Genotype VII Velogenic Isolate Using a Simple Infectious Cloning System
by: Nannan Wang, et al.
Published: (2020-09-01)

Protection against Different Genotypes of Newcastle Disease Viruses (NDV) Afforded by an Adenovirus-Vectored Fusion Protein and Live NDV Vaccines in Chickens
by: Helena L. Ferreira, et al.
Published: (2021-02-01)

Genotype characterization of commonly used Newcastle disease virus vaccine strains of India.
by: Sohini Dey, et al.
Published: (2014-01-01)

Genotype determination and sequencing of F glycoprotein gene of Newcastle disease viruses in Taiwan
by: Kao, Ying-Tai, et al.

Genotype Determination and Sequencing of F Glycoprotein Gene of Newcastle desease virsus in Taiwan
by: 高英泰
Published: (1997)

Study Of Chick Embryo Vaccination Against Newcastle And Newcastle With Gumboro
by: Abdel Ameer H. Zahid
Published: (2005-12-01)

Analysis of the Amino Acid Sequence of Fo Cleavage Site at
by: Lin, Yeou-Liang, et al.
Published: (1997)

Two mutations in the HR2 region of Newcastle disease virus fusion protein with a cleavage motif “RRQRRL” are critical for fusogenic activity
by: Yanhong Wang, et al.
Published: (2017-09-01)

A novel HIV vaccine targeting the protease cleavage sites
by: Hongzhao Li, et al.
Published: (2017-09-01)

Patho-epidemiological study on Genotype-XIII Newcastle disease virus infection in commercial vaccinated layer farms
by: J. H. Khorajiya, et al.
Published: (2015-03-01)

Rapid virulence prediction and identification of Newcastle disease virus genotypes using third-generation sequencing
by: Salman L. Butt, et al.
Published: (2018-11-01)

Identification of Newcastle disease virus subgenotype VII.2 in wild birds in Turkey
by: Nuri Turan, et al.
Published: (2020-08-01)

Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated newcastle disease virus vector.
by: Sunil K Khattar, et al.
Published: (2013-01-01)

Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt
by: Ibrahim Moharam, et al.
Published: (2021-04-01)

A novel HIV vaccine targets the 12 protease cleavage sites
by: Luo M, et al.
Published: (2012-09-01)

Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
by: Sunil K. Khattar, et al.
Published: (2014-01-01)

Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector.
by: Sunil K. Khattar, et al.
Published: (2014-01-01)